Analyze Diet
Veterinary sciences2025; 12(11); 1090; doi: 10.3390/vetsci12111090

The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses.

Abstract: Lipopolysaccharide (LPS) is frequently used in equine research to model clinical endotoxemia; however, there is no standardized protocol for inducing cytokine production in equine whole blood. To address this knowledge gap, the goal of this study was to compare the cytokine responses elicited by three different LPS stimulation protocols. Whole blood was collected from six healthy horses (aged 5-30 years; mixed breeds and genders) from the North Carolina State University teaching herd (IACUC #23-412). Sixty milliliters of heparinized blood were aseptically drawn and divided into 15 mL aliquots. Samples were stimulated with LPS at concentrations of 100 ng/mL, 1000 ng/mL, or using a two-hit model (500 ng/mL initially and again at 1.5 h). Incubation occurred at 37 °C on an orbital shaker for time points ranging from 1.5 h to 24 h. Cytokine concentrations were measured using the Cornell Equine Cytokine and Chemokine Panel and were compared to non-stimulated controls. LPS stimulation induced the production of TNF-α, IL-1β, IL-10, CCL5, and CCL11 in a time- and concentration-dependent manner. Notably, reliable and robust cytokine responses were observed only after 12 h of stimulation with either 1000 ng/mL or the two-hit 500/500 ng/mL protocol. These findings suggest that both the concentration and duration of LPS exposure significantly influence cytokine expression in equine whole blood. Therefore, the optimal stimulation protocol may vary depending on the specific cytokine of interest, and careful consideration of these variables is essential for designing reproducible and physiologically relevant ex vivo models of equine endotoxemia.
Publication Date: 2025-11-16 PubMed ID: 41295728PubMed Central: PMC12656798DOI: 10.3390/vetsci12111090Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated how different concentrations and exposure times of lipopolysaccharide (LPS) affect cytokine production in horse whole blood samples.
  • The goal was to identify optimal stimulation protocols for reliably inducing cytokine responses in an ex vivo model of equine endotoxemia.

Background

  • LPS is a component of the outer membrane of Gram-negative bacteria and commonly used to simulate endotoxemia (a systemic inflammatory response) in horse research.
  • Endotoxemia in horses can cause severe inflammatory responses, often characterized by increased production of cytokines, which are signaling proteins involved in immune regulation.
  • Despite widespread use, there was no standardized protocol for how best to stimulate equine whole blood with LPS to induce cytokine production.
  • This lack of standardization leads to variability in research outcomes, complicating comparisons and reproducibility.

Research Objectives

  • To compare cytokine responses in equine whole blood when stimulated with different LPS concentrations and exposure durations.
  • To determine which LPS stimulation protocols produce reliable and robust cytokine production ex vivo.

Methodology

  • Blood samples were collected from six healthy horses of mixed breed, age, and gender from a university teaching herd.
  • Blood was anticoagulated with heparin and divided into 15 mL aliquots for stimulation.
  • Three LPS stimulation protocols were tested:
    • Single exposure at 100 ng/mL LPS
    • Single exposure at 1000 ng/mL LPS
    • Two-hit model with 500 ng/mL LPS applied initially and repeated at 1.5 hours
  • Samples were incubated at 37 °C on an orbital shaker to simulate physiological conditions and ensure mixing, for times ranging from 1.5 to 24 hours.
  • Cytokine concentrations were measured using a specialized equine cytokine panel that detects TNF-α, IL-1β, IL-10, CCL5, and CCL11.
  • Results were compared against non-stimulated control samples to determine the effect of LPS stimulation.

Results

  • LPS stimulation triggered production of several key cytokines associated with inflammation and immune response:
    • Tumor necrosis factor-alpha (TNF-α)
    • Interleukin-1 beta (IL-1β)
    • Interleukin-10 (IL-10), an anti-inflammatory cytokine
    • Chemokines CCL5 and CCL11, which attract immune cells
  • The cytokine production depended on both the concentration of LPS and the duration of stimulation:
    • Lower concentration (100 ng/mL) or shorter stimulation times (under 12 hours) generated inconsistent or weak cytokine responses.
    • Higher concentration (1000 ng/mL) or the two-hit protocol (500 ng/mL twice) induced robust and reliable cytokine responses, particularly after 12 hours.
  • This indicates that both the amount of LPS and length of incubation critically affect the responsiveness of equine blood immune cells.

Conclusions and Implications

  • Optimal stimulation protocols for measuring cytokines ex vivo in equine whole blood require careful consideration of both LPS concentration and incubation time.
  • For strong and reproducible cytokine expression, stimulating with either 1000 ng/mL LPS or a two-hit 500/500 ng/mL protocol for at least 12 hours is recommended.
  • The choice of protocol may vary based on which cytokine(s) researchers are interested in, meaning protocols should be tailored to specific research questions.
  • These findings help standardize ex vivo models of equine endotoxemia, enhancing the consistency and translational relevance of future inflammatory and immunological studies in horses.
  • Ultimately, this contributes to better understanding, diagnosis, and treatment of endotoxemia-related diseases in horses by improving experimental design in this field.

Cite This Article

APA
Mitlyng N, Hobbs KJ, Cooper BL, Sheats MK. (2025). The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses. Vet Sci, 12(11), 1090. https://doi.org/10.3390/vetsci12111090

Publication

ISSN: 2306-7381
NlmUniqueID: 101680127
Country: Switzerland
Language: English
Volume: 12
Issue: 11
PII: 1090

Researcher Affiliations

Mitlyng, Natalie
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27695, USA.
Hobbs, Kallie J
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27695, USA.
  • Department of Clinical Sciences, Texas A&M University, College Station, TX 77845, USA.
Cooper, Bethanie L
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27695, USA.
Sheats, M Katie
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27695, USA.

Grant Funding

  • Unknown / National Institute for Health and Care Research

Conflict of Interest Statement

The author declare no conflicts of Interest.

References

This article includes 22 references
  1. Sheats M.K.. A Comparative Review of Equine SIRS, Sepsis, and Neutrophils.. Front. Vet. Sci. 2019;6:69.
    doi: 10.3389/fvets.2019.00069pmc: PMC6424004pubmed: 30931316google scholar: lookup
  2. Ferrara J.L., Abhyankar S., Gilliland D.G.. Cytokine storm of graft-versus-host disease: A critical effector role for interleukin-1.. Transpl. Proc. 1993;25:1216–1217.
    pubmed: 8442093
  3. Werners A.H., Bull S., Fink-Gremmels J.. Endotoxaemia: A review with implications for the horse.. Equine Vet. J. 2005;37:371–383.
    doi: 10.2746/0425164054529418pubmed: 16028631google scholar: lookup
  4. MacKay R.J., Merritt A.M., Zertuche J.M., Whittington M., Skelley L.A.. Tumor necrosis factor activity in the circulation of horses given endotoxin.. Am. J. Vet. Res. 1991;52:533–538.
    doi: 10.2460/ajvr.1991.52.04.533pubmed: 2053720google scholar: lookup
  5. MacKay R.J., Lester G.D.. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin.. Am. J. Vet. Res. 1992;53:1285–1289.
    doi: 10.2460/ajvr.1992.53.08.1285pubmed: 1510298google scholar: lookup
  6. Nieto J.E., MacDonald M.H., Braim A.E., Aleman M.. Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo.. Equine Vet. J. 2009;41:717–719.
    doi: 10.2746/042516409X464780pubmed: 19927593google scholar: lookup
  7. Eckert R.E., Neuder L.E., Bell J.L., Trujillo J.C., Jones S.L.. The role of p38 mitogen-activated kinase (MAPK) in the mechanism regulating cyclooxygenase gene expression in equine leukocytes.. Vet. Immunol. Immunopathol. 2007;118:294–303.
    doi: 10.1016/j.vetimm.2007.06.001pubmed: 17614138google scholar: lookup
  8. Tadros E.M., Frank N.. Effects of continuous or intermittent lipopolysaccharide administration for 48 hours on the systemic inflammatory response in horses.. Am. J. Vet. Res. 2012;73:1394–1402.
    doi: 10.2460/ajvr.73.9.1394pubmed: 22924721google scholar: lookup
  9. Martin E.M., Messenger K.M., Sheats M.K., Jones S.L.. Misoprostol Inhibits Lipopolysaccharide-Induced Pro-inflammatory Cytokine Production by Equine Leukocytes.. Front. Vet. Sci. 2017;4:160.
    doi: 10.3389/fvets.2017.00160pmc: PMC5624997pubmed: 29034249google scholar: lookup
  10. Cornell University Animal Health Diagnostic Center. [(accessed on 16 October 2025)]. Available online: https://ahdc.vet.cornell.edu.
  11. Rütten S., Schusser G.F., Abraham G., Schrödl W.. Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood.. BMC Vet. Res. 2016;12:117.
    doi: 10.1186/s12917-016-0742-4pmc: PMC4912716pubmed: 27316332google scholar: lookup
  12. Yao Z., Mates J.M., Cheplowitz A.M., Hammer L.P., Maiseyeu A., Phillips G.S., Wewers M.D., Rajaram M.V., Robinson J.M., Anderson C.L.. Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein.. J. Immunol. 2016;197:2390–2399.
    doi: 10.4049/jimmunol.1600702pmc: PMC5010928pubmed: 27534554google scholar: lookup
  13. Wang Y., Yu P., Li Y., Zhao Z., Wu X., Zhang L., Feng J., Hong J.S.. Early-Released Interleukin-10 Significantly Inhibits Lipopolysaccharide-Elicited Neuroinflammation In Vitro.. Cells. 2021;10:2173.
    doi: 10.3390/cells10092173pmc: PMC8466025pubmed: 34571824google scholar: lookup
  14. Carlini V., Noonan D.M., Abdalalem E., Goletti D., Sansone C., Calabrone L., Albini A.. The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions.. Front. Immunol. 2023;14:1161067.
    doi: 10.3389/fimmu.2023.1161067pmc: PMC10287165pubmed: 37359549google scholar: lookup
  15. Byrne A., Reen D.J.. Lipopolysaccharide Induces Rapid Production of IL-10 by Monocytes in the Presence of Apoptotic Neutrophils1.. J. Immunol. 2002;168:1968–1977.
    doi: 10.4049/jimmunol.168.4.1968pubmed: 11823533google scholar: lookup
  16. Fang D, Zhu J. Molecular switches for regulating the differentiation of inflammatory and IL-10-producing anti-inflammatory T-helper cells. Cell Mol. Life Sci. 2020;77:289–303.
    doi: 10.1007/s00018-019-03277-0pmc: PMC11105075pubmed: 31432236google scholar: lookup
  17. Ouyang W, O’Garra A. IL-10 Family Cytokines IL-10 and IL-22: From Basic Science to Clinical Translation. Immunity 2019;50:871–891.
    doi: 10.1016/j.immuni.2019.03.020pubmed: 30995504google scholar: lookup
  18. Bai D, Han A, Cong S. The effect of down-regulation of CCL5 on lipopolysaccharide-induced WI-38 fibroblast injury: A potential role for infantile pneumonia. Iran. J. Basic Med. Sci. 2018;21:449–454.
  19. Roth S.P., Liso G, Brehm W, Wagner B, Schnabel C.L., Troillet A. Selected cytokine and chemokine concentrations in equine autologous conditioned serum are similar under defined and practically relevant storage conditions. Front. Vet. Sci. 2025;12:1588240.
    doi: 10.3389/fvets.2025.1588240pmc: PMC12150348pubmed: 40496923google scholar: lookup
  20. Dong H, Rowland I, Yaqoob P. Comparative effects of six probiotic strains on immune function in vitro. Br. J. Nutr. 2012;108:459–470.
    doi: 10.1017/S0007114511005824pubmed: 22054064google scholar: lookup
  21. Hessle C, Hanson L, Wold A. Interleukin-10 Produced by the Innate Immune System Masks In Vitro Evidence of Acquired T-Cell Immunity to E. coli. Scand. J. Immunol. 2000;52:13–20.
  22. Rarick M, McPheeters C, Bright S, Navis A, Skefos J, Sebastiani P, Montano M. Evidence for cross-regulated cytokine response in human peripheral blood mononuclear cells exposed to whole gonococcal bacteria in vitro. Microb. Pathog. 2006;40:261–270.
    doi: 10.1016/j.micpath.2006.02.003pubmed: 16626926google scholar: lookup

Citations

This article has been cited 0 times.